Precision Medicine for L/GCMN and Melanoma 2

Recruiting Observational Study
Melanoma (Skin Cancer) Nevi and Melanomas Congenital Melanocytic Nevus
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Fundacion Clinic per a la Recerca Biomédica · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The primary objective is to evaluate the possibility of using minimally and non-invasive technologies (skin patch and breath analyzer) based on the detection of volatile organic compounds (VOCs) for the early identification of metastases. The secondary objective is to evaluate the usability of these technologies in the follow up of high-risk melanoma patients.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Be over 18 years old * Have a histopathological confirmed melanoma diagnosis (stage II, III or IV AJCC) Exclusion Criteria: * Not signing the informed consent form * Present other cancers or chronic diseases (such as diabetes, asthma, etc.), which may affect the volatile org…
Contacts

Susana Puig Sardà, PhD, MD

+34932275400

spuig@clinic.cat

CONTACT

Adrián López Canosa, PhD

lopez64@recerca.clinic.cat

CONTACT